XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
PremiumPress ReleasesXOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
3M ago
Xoma receives $8.1M milestone related to Day One’s sale of PRV
Premium
The Fly
Xoma receives $8.1M milestone related to Day One’s sale of PRV
3M ago
LadRx, ImmunityBio mutually agree to terminate Aldoxorubicin license
Premium
The Fly
LadRx, ImmunityBio mutually agree to terminate Aldoxorubicin license
4M ago
Xoma acquires economic interest in three assets from Dare Bioscience
PremiumThe FlyXoma acquires economic interest in three assets from Dare Bioscience
5M ago
Dare Bioscience secures $22M in non-dilutive strategic royalty financing
Premium
The Fly
Dare Bioscience secures $22M in non-dilutive strategic royalty financing
5M ago
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
Premium
Press Releases
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
5M ago
XOMA Corporation Announces Closing of Tender Offer
PremiumPress ReleasesXOMA Corporation Announces Closing of Tender Offer
6M ago
XOMA Declares Quarterly Preferred Stock Dividends
Premium
Press Releases
XOMA Declares Quarterly Preferred Stock Dividends
6M ago
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
Premium
Press Releases
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100